Interferon Alfa-2b (International)
In the US, Interferon Alfa-2b (interferon alfa-2b systemic) is a member of the drug class antineoplastic interferons and is used to treat Angioblastoma, Condylomata Acuminata, Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma, Follicular Lymphoma, Hairy Cell Leukemia, Hepatitis B, Hepatitis C, Idiopathic Thrombocytopenic Purpura, Kaposi's Sarcoma and Melanoma.
US matches:
Scheme
USAN
ATC (Anatomical Therapeutic Chemical Classification)
L03AB05,S01AD05
CAS registry number (Chemical Abstracts Service)
0099210-65-8
Chemical Formula
C860-H1353-N229-O255-S9
Molecular Weight
19269
Therapeutic Categories
Antineoplastic agent
Antiviral agent: Treatment of hepatitis
Biological response modifier, BRM
Immunomodulator
Foreign Names
- Interferonum alfa-2b (Arg-23; His-34) (Latin)
- Interferon alfa-2b (Arg-23; His-34) (German)
- Interféron alfa-2b (Arg-23; His-34) (French)
- Interferón alfa-2b (Arg-23; His-34) (Spanish)
Generic Names
- Interferon Alfa-2b (OS: USAN, BAN)
- Interferon Alfa-2b (Genetical Recombination) (OS: JAN)
- IFNalpha2b (IS)
- r-IFN-Alfa-2b (IS)
- Sch 30500 (IS)
- Interferon Alfa-2 Concentrated Solution (PH: BP 2016)
- Interferon Alfa-2b (Genetical Recombination) (PH: JP XVI)
Brand Names
- Alfaferone
Alfa Wassermann, Lebanon - Allergoferon [+ Loratadine]
Firn M, Russian Federation - Allergoferon Beta [+ Betamethasone]
Firn M, Russian Federation - Alphaferoi
Akber Brothers, Pakistan - An Da Fen
Anke Biotechnology Group, China - An Fu Long
HuaLiDa Biotechnology, China - An Te Fu
Neptunus Pharmaceutical, China - Anferon
Atco, Pakistan - Bioferon
Bio Sidus, Thailand; Sidus, Argentina; Sidus, Paraguay; Sidus, Uruguay; Instituto Sidus, Lebanon - Blauferon-B
Pharmatec, Pakistan - Blauferon-B 3 MUI
Blausiegel, Uruguay - Cell-aid
Werrick, Pakistan - Ceron-alfa
Biocare, Pakistan - Chang Sheng De Jia
Changchun Institute of Biological Products, China - Chang Sheng Fu Kang
Changchun Institute of Biological Products, China - Enduferon
Heber, Philippines - Genferon [+ Taurine]
ZAO "BIOKAD", Georgia - Green-alpha
Genesis, Pakistan - Heberon-alpha
Macter, Pakistan - Inf 3Mui
Bago, Paraguay - Inrec
Clausen, Uruguay - Intefen
NovaMed, Pakistan - Inter 2B
Biosidus, Argentina - Interferon Alfa 2b Cassara
Promofarma, Uruguay; Varifarma, Argentina - Interferon Alfa 2b V y T Farma
V y T Farma, Paraguay - Interferon Alfa-2b Humano Recombinante Bago
Laboratorio Bago, Chile - Interferonas alfa-2b
Sicor Biotech, Lithuania - Interlong
Hepacare, Pakistan; Neptunus Pharmaceutical, China - Intron A
Bayer Schering, Iran; M.S.D., Portugal; Merck Canada, Canada; Merck Sharp & Dohme, Australia; Merck Sharp & Dohme, Bosnia & Herzegowina; Merck Sharp & Dohme, Hong Kong; Merck Sharp & Dohme, Croatia (Hrvatska); Merck Sharp & Dohme, Mexico; Merck Sharp & Dohme, New Zealand; Merck Sharp & Dohme, Poland; Merck Sharp & Dohme, Romania; Merck Sharp & Dohme, Slovenia; MSD, Japan; MSD Belgium, Belgium; MSD Belgium, Luxembourg; MSD Merck Sharp & Dohme, Germany; Schering, United Arab Emirates; Schering, Egypt; Schering, Iraq; Schering, Jordan; Schering, Qatar; Schering, Saudi Arabia; Schering, United States; Schering, Yemen; Schering-Plough, Bahrain; Schering-Plough, Indonesia; Schering-Plough, Israel; Schering-Plough, Kuwait; Schering-Plough, Lebanon; Schering-Plough, Philippines; Schering-Plough, Serbia; Schering-Plough, Russian Federation; Schering-Plough, Syria; Schering-Plough, Venezuela; Schering-Plough, South Africa; Schering-Plough Labo, Macedonia - Intron A (Merck Sharp & Dohme
China MSD, China - Intron A
Merck Sharp & Dohme Pharma Singapore, Singapore - Intron A 10 Mio IE
MSD, Switzerland - Intron A 30 Mio IE
MSD, Switzerland - Intron A 60 Mio IE
MSD, Switzerland - Intron A Multi-Dose
Schering-Plough, Taiwan - Intron A Redipen
Merck Sharp & Dohme, Australia - Intron Redipen
Schering-Plough, Venezuela - IntronA
Merck, Iceland; Merck Sharp & Dohme, Chile; Merck Sharp & Dohme, United Kingdom; Merck Sharp & Dohme, Greece; Merck Sharp & Dohme, Lithuania; MSD, Czech Republic; MSD, Denmark; MSD, Finland; MSD, Ireland; MSD, Norway; MSD, Sweden; MSD, Slovakia; Schering-Plough, Italy; Schering-Plough, Lithuania - Introna
Merck Sharp & Dohme, Cyprus; Merck Sharp & Dohme, Estonia; Merck Sharp & Dohme, Spain - Intron-A
Atco, Pakistan; Merck Sharp & Dohme, Mexico; Merck Sharp & Dohme, Malaysia; MSD Merck Sharp & Dohme, Turkey - IntronA 18 millió NE
MSD Pharma, Hungary - IntronA 18 Mio. I.E.
Merck Sharp & Dohme, Austria - IntronA 18 Mio. I.E./3ml
Merck Sharp & Dohme, Austria - IntronA 25 Mio. I.E./2,5ml
Merck Sharp & Dohme, Austria - IntronA 30 millió NE
MSD Pharma, Hungary - IntronA 30 Mio. I.E.
Merck Sharp & Dohme, Austria - IntronA 60 millió NE
MSD Pharma, Hungary - IntronA 60 Mio. I.E.
Merck Sharp & Dohme, Austria - Jie Fu
HuaLiDa Biotechnology, China - Kaifu
Kawin Technologie, China - Kalferon
Kalbe, Indonesia - Laferon
Rubikon, Georgia - Lai Fu Long
Beisheng Medicine Industry Hansheng Pharmaceutical, China - Li Fen Neng
Hayao Pharmaceutical Group Holding, China - Li Ya Mei
Hayao Pharmaceutical Group Holding, China - Longhuanuo
Binhai Xinbao, China - Ophthalmoferon [+ Diphenhydramine]
ZAO, Georgia - Peg-Intron
Schering-Plough, Oman - Realdiron
Sicor Biotech, Lithuania; Sicor Biotech, Serbia - Rebetron [+ Ribavirin]
Schering-Plough, Kuwait - Refergen
Sicor Biotech, Lithuania - Reliferon
Ambica, Philippines - Ruferon-Rn
Rubikon, Georgia - Urifron
Probiomed, Mexico - Urifrón
Probiomed, Dominican Republic; Probiomed, Guatemala; Probiomed, Honduras; Probiomed, El Salvador - Viferon
Feron, Georgia - Viraferon
Fulford, India; Schering-Plough, Lithuania - Yi Sheng
Kawin Technologie, China - You Ni Long
Tongyong Tongmeng Pharmaceutical, China
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| USAN | United States Adopted Name |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.